Importance of surgery as salvage treatment after high dose chemotherapy failure in germ cell tumors

被引:18
|
作者
Fléchon, A
Rivoire, M
Biron, P
Droz, JP
机构
[1] Ctr Leon Berard, Dept Med Oncol, F-69373 Lyon, France
[2] Ctr Leon Berard, Dept Surg, F-69373 Lyon, France
来源
JOURNAL OF UROLOGY | 2001年 / 165卷 / 06期
关键词
germinoma; testes; mediastinum; drug therapy; salvage therapy;
D O I
10.1016/S0022-5347(05)66243-X
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: The survival of patients with germ cell cancer after failed high dose chemotherapy is poor. We retrospectively reviewed the various treatment choices in this situation. Materials and Methods: From March 1986 to July 1996, 32 patients had disease progression after high dose cisplatin based chemotherapy plus hematopoietic stem cell support. Patients received high dose chemotherapy in the first line (11) or salvage (21) setting. Results: There was relapse after a complete or partial marker negative response after high dose chemotherapy in 19 cases at a median time to disease progression of 7 months (range 1.5 to 72). Salvage treatment involved chemotherapy alone in 5 cases, chemotherapy plus surgery in 6, surgery plus radiotherapy in 3, surgery alone in 2, combined radiotherapy, chemotherapy and surgery in 1, and no treatment in 1 due to a rapid disease course. The most common chemotherapy regimen was combined vinorelbine, ifosfamide and epirubicin. Eight patients achieved a complete response with the resection of all residual disease. At long-term followup 2 patients have been continuously disease-free for 84 and 109 months, respectively. After high dose chemotherapy 13 patients had evidence of disease, including 4 with a partial marker positive response and 9 with progressive disease. Salvage treatment involved chemotherapy plus surgery in 6 cases, chemotherapy alone in 2, no treatment in 2, and radiotherapy plus chemotherapy, radiotherapy alone and surgery alone in 1 each. One patient with progressive disease and 3 with a partial marker positive response achieved a complete response after salvage surgery, and combined surgery and high dose chemotherapy, respectively. These 4 patients have been continuously free of disease for 105, 95, 92 and 72 months, respectively. Conclusions: Six of the 32 patients with relapse or progressive disease after high dose chemotherapy have been free of disease in the long term. The most effective treatment was the resection of all residual masses. Chemotherapy had only marginal activity and the efficacy of radiotherapy seems to have been nil.
引用
收藏
页码:1920 / 1926
页数:7
相关论文
共 50 条
  • [1] Salvage high-dose chemotherapy for germ cell tumors
    Feldman, Darren R.
    Powles, Thomas
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2015, 33 (08) : 355 - 362
  • [2] High Dose Chemotherapy as Salvage Treatment for Unresectable Late Relapse Germ Cell Tumors
    Lorch, Anja
    Rick, Oliver
    Wuendisch, Thomas
    Hartmann, Joerg-Thomas
    Bokemeyer, Carsten
    Beyer, Joerg
    JOURNAL OF UROLOGY, 2010, 184 (01): : 168 - 173
  • [3] Management of residual tumor after salvage high-dose chemotherapy in patients with germ cell tumors
    Rick, O
    Bokemeyer, C
    Schirren, J
    Braun, T
    Weissbach, L
    Siegert, W
    Beyer, J
    BONE MARROW TRANSPLANTATION, 2003, 31 : S193 - S193
  • [4] High-dose chemotherapy as salvage treatment in germ cell tumors: A Multivariate analysis of prognostic variables
    Beyer, J
    Kramar, A
    Mandanas, R
    Linkesch, W
    Greinix, A
    Droz, JP
    Pico, JL
    Diehl, A
    Bokemeyer, C
    Schmoll, HJ
    Nichols, CR
    Einhorn, LH
    Siegert, W
    JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (10) : 2638 - 2645
  • [5] Salvage treatment in germ cell tumors. High-dose chemotherapy and the impact of prognostic factors
    Lorch, A.
    Oechsle, K.
    Bokemeyer, C.
    Beyer, J.
    UROLOGE, 2009, 48 (04): : 364 - 371
  • [6] High-dose chemotherapy for salvage treatment of germ cell tumors: Charite, Virchow Klinikum, Berlin
    Siegert, W
    Rick, O
    Beyer, J
    BONE MARROW TRANSPLANTATION, 1998, 22 : S7 - S9
  • [7] Prognostic factors for high-dose chemotherapy (HDCT) as salvage treatment in germ cell tumors (GCT)
    Beyer, J
    Kramar, A
    Mandanas, R
    Linkesch, W
    Greinix, A
    Droz, JP
    Pico, JL
    Diehl, A
    Bokemeyer, C
    Schmoll, HJ
    Nichols, CR
    Einhorn, LH
    Siegert, W
    BONE MARROW TRANSPLANTATION, 1998, 22 : S10 - S10
  • [8] Is high-dose chemotherapy superior to conventional chemotherapy as first salvage treatment for patients with metastatic germ cell tumors?
    Bachir, Bassel G.
    Kassouf, Wassim
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2012, 6 (02): : 119 - 120
  • [9] HIGH-DOSE CARBOPLATIN AND ETOPOSIDE FOR SALVAGE CHEMOTHERAPY OF GERM-CELL TUMORS
    LAMPE, H
    DEARNALEY, DP
    PRICE, A
    MEHTA, J
    POWLES, R
    NICHOLLS, J
    HORWICH, A
    EUROPEAN JOURNAL OF CANCER, 1995, 31A (05) : 717 - 723
  • [10] The Role of Salvage High-Dose Chemotherapy in Relapsed Male Germ Cell Tumors
    Oing, Christoph
    Lorch, Anja
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 (06) : 365 - 369